Elevance Health, Inc. (ELV)
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.
Elevance Health - Piggy Bank Or Headache?
Elevance and peers face earnings pressure from rising medical costs, driven by deferred care, expensive drugs, and persistent medical inflation. The segment has re-rated, and now offers good value. Investor sentiment has returned, and capital is rotating into healthcare.
Elevance Shoots for the Stars But Lands at 3.5: $375M Bonus Gone?
Federal judge dismisses ELV's lawsuit challenging Medicare Advantage star ratings, leading to a $375M bonus loss tied to its star score.
Food as Medicine: Elevance Health & NACHC Integrate Nutrition in Care
ELV partners with NACHC to bring Food as Medicine into primary care, targeting nutritional insecurities and chronic disease.
When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion
ELV trims 2025 outlook as medical costs climb, but commercial growth and Carelon's momentum aim to steady performance.
When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD Decline
ELV's 20% YTD slump reflects shrinking memberships, rising costs and deepening analyst pessimism despite long-term growth levers.
3 Stocks That Could Double Before 2027
These stocks have high upside potential through 2027. They're sitting at solid discounts and have good fundamentals.
Elevance Health: CEO Buys As CareBridge Drives Strong Growth
On July 18, the CEO bought $2.4MM worth, after the sell-off following the last earnings call. Carelon Services is growing fast, supported by the December acquisition of CareBridge. The aging population, the rising interest in well-being, and the potential expansion in Florida and Texas are a ray of light in the current gloomy context of the company.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
S&P 500 Gains and Losses Today: Pepsi Stock Turns Higher; Elevance Health Tumbles
Major U.S. equities indexes pushed higher Thursday as a report revealed an increase in retail sales in June, suggesting that consumer spending remains strong despite tariff concerns.
Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs
ELV's Q2 EPS slides 12.6% y/y and misses estimates as rising Medicaid and ACA costs weigh on the results.
Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV ) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Koziara Boudreaux - President, CEO & Director Mark Bradley Kaye - Executive VP & CFO Morgan Kendrick - Corporate Participant Nathan Allen Rich - Vice President of Investor Relations Peter David Haytaian - Executive VP and President of Carelon & CarelonRx Conference Call Participants Albert J. William Rice - UBS Investment Bank, Research Division Andrew Mok - Barclays Bank PLC, Research Division Ann Kathleen Hynes - Mizuho Securities USA LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Benjamin Whitman Mayo - Leerink Partners LLC, Research Division David Howard Windley - Jefferies LLC, Research Division Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division George Robert Hill - Deutsche Bank AG, Research Division Jason Paul Cassorla - Guggenheim Securities, LLC, Research Division Joshua Richard Raskin - Nephron Research LLC Justin Lake - Wolfe Research, LLC Kevin Mark Fischbeck - BofA Securities, Research Division Lance Arthur Wilkes - Sanford C.
